Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12972481.
- Also identified by PMC identifier 1754312.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hypertension is common in the antiphospholipid (Hughes) syndrome (APS) and its cause is poorly understood. Anecdotal evidence suggests that renal artery stenosis (RAS) may be a relevant and treatable cause of hypertension. To investigate the prevalence of RAS in patients with APS and hypertension. Three groups of patients were evaluated: (1) 77 patients with positive antiphospholipid antibodies (aPL) (60 secondary APS, 11 primary APS, and 6 with aPL only) and uncontrolled hypertension who were receiving two or more antihypertensive drugs; (2) 91 patients (</=50 years) attending hypertension clinics;(3) 92 normotensive healthy, potential renal transplant donors. Magnetic resonance renal angiography was used to image the renal arteries in all three groups. Group 1: 20/77 (26%) patients had evidence of RAS (16 unilateral and 4 bilateral). Sixteen patients (80%) had smooth well defined stenoses in the proximal third of the renal artery. Three further patients had irregular arteries without distinct stenosis. Group 2: 7/91 (8%) hypertensive patients had RAS (chi(2)=10.3, p<0.001 v group 1). Group 3: 3/92 (3%) healthy donors had RAS (chi(2)=18.2, p<0.0001 v group 1). A significantly increased prevalence of RAS (26%) was found in patients with APS and hypertension, compared with relatively young (</=50 years) hypertensive controls and healthy potential donors.
Medical subject headings
- Antiphospholipid Syndrome
- Hypertension
- Renal Artery Obstruction